Making sense of antisense oligonucleotides: A narrative review

Muscle & Nerve
Neelam Goyal, Pushpa Narayanaswami

Abstract

Synthetic nucleic acid sequences that bind to ribonucleic acid (RNA) through Watson-Crick base pairing are known as antisense oligonucleotides (ASOs) because they are complementary to "sense strand" nucleic acids. ASOs bind to selected sequences of RNA and regulate the expression of genes by several mechanisms depending on their chemical properties and targets. They can be used to restore deficient protein expression, reduce the expression of a toxic protein, modify functional effects of proteins, or reduce toxicity of mutant proteins. Two ASOs were approved by the U.S. Food and Drug Administration in 2016: eteplirsen for Duchenne muscular dystrophy and nusinersen for spinal muscular atrophy. Clinical trials in amyotrophic lateral sclerosis and familial amyloid polyneuropathy are ongoing. We review the chemistry, pharmacology, and mechanisms of action of ASOs, preclinical data, and clinical trials in neuromuscular diseases and discuss some ethical, regulatory, and policy considerations in the clinical development and use of ASOs. Muscle Nerve 57: 356-370, 2018.

References

Jan 1, 1978·Proceedings of the National Academy of Sciences of the United States of America·P C Zamecnik, M L Stephenson
Nov 1, 1990·Human Genetics·A H BeggsL M Kunkel
Jun 1, 1997·Antisense & Nucleic Acid Drug Development·J Summerton, D Weller
Aug 4, 1999·The Journal of Pediatrics·L HaatajaL Dubowitz
Mar 10, 2001·Nature·E S LanderUNKNOWN International Human Genome Sequencing Consortium
Jul 27, 2001·Human Molecular Genetics·J C van DeutekomG J van Ommen
Oct 9, 2001·Human Molecular Genetics·A MankodiC A Thornton
Apr 30, 2002·Clinical Pharmacokinetics·Richard S GearyLisa R Grillone
Feb 26, 2003·Genes & Development·Nuno André Faustino, Thomas A Cooper
Mar 11, 2003·Annual Review of Biochemistry·Douglas L Black
Apr 2, 2003·Human Molecular Genetics·Annemieke Aartsma-RusJudith C T van Deutekom
Apr 16, 2003·European Journal of Biochemistry·Jens Kurreck
Nov 26, 2003·Lancet Neurology·Francesco MuntoniAlessandra Ferlini
Feb 13, 2004·The Journal of Biological Chemistry·Hongjiang WuStanley T Crooke
Aug 6, 2004·Molecular Therapy : the Journal of the American Society of Gene Therapy·Mattie Bremmer-BoutJudith C T van Deutekom
Nov 25, 2005·Current Pharmaceutical Design·S El-AndaloussiUlo Langel
Jan 20, 2006·Muscle & Nerve·Merrill D BensonKyle W Sloop
Aug 1, 2006·The Journal of Clinical Investigation·Richard A SmithDon W Cleveland
Mar 29, 2007·Proceedings of the National Academy of Sciences of the United States of America·Liutao DuRichard A Gatti
Jul 31, 2007·Neuromuscular Disorders : NMD·Jessica M O'HagenDarryl C De Vivo
Dec 28, 2007·The New England Journal of Medicine·Judith C van DeutekomGert-Jan B van Ommen
Mar 29, 2008·American Journal of Human Genetics·Yimin HuaAdrian R Krainer
Dec 3, 2008·BMC Medical Genetics·Laura van VlietAnnemieke Aartsma-Rus
Dec 24, 2008·Molecular and Cellular Biology·Barrington G BurnettKenneth H Fischbeck
Jan 8, 2009·Oligonucleotides·John BaumanRyszard Kole
Jan 14, 2009·Archives of Neurology·Toshifumi YokotaEric P Hoffman
Feb 5, 2009·Annals of Neurology·Jeffrey D Rothstein
Feb 21, 2009·The FEBS Journal·Susana M Cerritelli, Robert J Crouch

❮ Previous
Next ❯

Citations

Dec 20, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Maria S Ramirez, Marcelo E Tolmasky
Aug 31, 2018·Organic & Biomolecular Chemistry·Naohiro HorieSatoshi Obika
Jun 23, 2019·Human Molecular Genetics·Ryotaro OmichiRichard J H Smith
Apr 16, 2019·Frontiers in Pharmacology·Davide Di FuscoGiovanni Monteleone
Aug 1, 2020·Frontiers in Cellular Neuroscience·Lucy S FrenchLivia S Carvalho
Sep 21, 2018·Frontiers in Molecular Neuroscience·Roberta SchellinoAlessandro Vercelli
May 17, 2019·The Journal of Pediatric Pharmacology and Therapeutics : JPPT : the Official Journal of PPAG·Erin E Neil, Elizabeth K Bisaccia
Dec 11, 2019·Cells·Roberta SchellinoAlessandro Vercelli
May 21, 2018·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Mitchell G Miglis, Srikanth Muppidi
Aug 2, 2019·Chemical & Pharmaceutical Bulletin·Kenji KikutaShigeki Sasaki
May 7, 2020·Frontiers in Chemistry·Nihay Laham-KaramPiia Kokkonen
Oct 8, 2020·Nucleic Acid Therapeutics·Suxiang ChenRakesh N Veedu
Nov 3, 2020·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Paula I Fuller-CarterLivia S Carvalho
Dec 31, 2019·Biotechnology Advances·Cui-Cui MaYu-Quan Wei
Sep 8, 2021·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Jennifer HardyRushab Choksi
Nov 6, 2021·Chemical Society Reviews·Kristie E Darrah, Alexander Deiters
Nov 20, 2021·Functional Plant Biology : FPB·Anna Wdowikowska, Malgorzata Janicka

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Amyloidogenesis-associated Polyneuropathy

Amyloid deposits around nerves can damage and disrupt smooth information processing between the brain and organs. Here is the latest research on amyloidosis-associated polyneuropathies.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

Related Papers

Advanced Drug Delivery Reviews
Melvin M EversWilleke M C van Roon-Mom
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Kate Traynor
American Journal of Physical Medicine & Rehabilitation
Fernando Augusto PessolanoEduardo Luis De Vito
© 2022 Meta ULC. All rights reserved